JPS6245231B2 - - Google Patents
Info
- Publication number
- JPS6245231B2 JPS6245231B2 JP59115421A JP11542184A JPS6245231B2 JP S6245231 B2 JPS6245231 B2 JP S6245231B2 JP 59115421 A JP59115421 A JP 59115421A JP 11542184 A JP11542184 A JP 11542184A JP S6245231 B2 JPS6245231 B2 JP S6245231B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- reaction
- dimethylthiazolidine
- formula
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 206010034972 Photosensitivity reaction Diseases 0.000 claims description 4
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- CJVKUCKSANIOEH-UHFFFAOYSA-N 2,2-dimethyl-1,3-thiazolidin-5-ol Chemical class CC1(SC(CN1)O)C CJVKUCKSANIOEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 11
- SNPQRYOQWLOTFA-UHFFFAOYSA-N 2,2-dimethyl-1,3-thiazolidine Chemical class CC1(C)NCCS1 SNPQRYOQWLOTFA-UHFFFAOYSA-N 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- -1 β-lactam compound Chemical class 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000003504 photosensitizing agent Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- DKBHZOAJEBBPPM-UHFFFAOYSA-N 1,3-thiazolidin-5-ol Chemical compound OC1CNCS1 DKBHZOAJEBBPPM-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- YNHJECZULSZAQK-UHFFFAOYSA-N tetraphenylporphyrin Chemical compound C1=CC(C(=C2C=CC(N2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3N2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 YNHJECZULSZAQK-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 1
- BXPLPEUHOCVJTK-UHFFFAOYSA-N 5-hydroperoxy-2,2-dimethyl-1,3-thiazolidine Chemical class CC1(C)NCC(OO)S1 BXPLPEUHOCVJTK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- RWSTZEOFHUPGPA-UHFFFAOYSA-N O(O)C1CNCS1 Chemical class O(O)C1CNCS1 RWSTZEOFHUPGPA-UHFFFAOYSA-N 0.000 description 1
- QMHAHUAQAJVBIW-UHFFFAOYSA-N [methyl(sulfamoyl)amino]methane Chemical compound CN(C)S(N)(=O)=O QMHAHUAQAJVBIW-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- NCBFTYFOPLPRBX-UHFFFAOYSA-N dimethyl azodicarboxylate Substances COC(=O)N=NC(=O)OC NCBFTYFOPLPRBX-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- JEHCHYAKAXDFKV-UHFFFAOYSA-J lead tetraacetate Chemical compound CC(=O)O[Pb](OC(C)=O)(OC(C)=O)OC(C)=O JEHCHYAKAXDFKV-UHFFFAOYSA-J 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- NCBFTYFOPLPRBX-AATRIKPKSA-N methyl (ne)-n-methoxycarbonyliminocarbamate Chemical compound COC(=O)\N=N\C(=O)OC NCBFTYFOPLPRBX-AATRIKPKSA-N 0.000 description 1
- KFYOQUXLXDGFPE-UHFFFAOYSA-N methyl 3-benzoyl-2,2-dimethyl-1,3-thiazolidine-4-carboxylate Chemical compound COC(=O)C1CSC(C)(C)N1C(=O)C1=CC=CC=C1 KFYOQUXLXDGFPE-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Description
【発明の詳細な説明】
本発明は2・2−ジメチル−5−ヒドロキシチ
アゾリジン誘導体の合成方法に関し、特に、β−
ラクタム系抗生物質であるセフアロスポリン合成
における重要な中間体として有用な上記5−ヒド
ロキシチアゾリジンの改良された製造方法に関す
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for synthesizing 2,2-dimethyl-5-hydroxythiazolidine derivatives, particularly β-
The present invention relates to an improved method for producing the above-mentioned 5-hydroxythiazolidine, which is useful as an important intermediate in the synthesis of cephalosporin, a lactam antibiotic.
セフアロスポリンはペニシリンと共に現在広範
に用いられている有用な薬剤である。セフアロス
ポリンの合成に関しては、例えばJ.Am.Chem.
Soc、88、852頁に記載の、Woodward氏等のセフ
アロスポリンCの全合成方法が参照される。この
セフアロスポリンCあるいはペニシリン合成にお
いては、基本構造要素として、次式で示される重
要な中間体化合物であるβ−ラクタム化合物(H)を
経由する。 Cephalosporin is a useful drug that is currently widely used along with penicillin. Regarding the synthesis of cephalosporin, see, for example, J.Am.Chem.
Reference is made to the total synthesis method for cephalosporin C of Woodward et al., described in Soc, 88, 852. In the synthesis of cephalosporin C or penicillin, a β-lactam compound (H), which is an important intermediate compound represented by the following formula, is used as a basic structural element.
このβ−ラクタム化合物(H)の製造工程を上記文
献の記載から要約すると、次表の通りである。 The manufacturing process of this β-lactam compound (H) is summarized from the description in the above-mentioned literature as shown in the following table.
本発明者等は、上記のβ−ラクタム製造工程に
おいて、特に上記の化合物(C)から(D)を経由して(E)
の2・2−ジメチル−5−ヒドロキシチアゾリジ
ン化合物に至る工程について検討し、その必須要
件とするジメチルアゾジカルボキシレートを用い
るヒドラゾジエステル化および毒性の高い四酢酸
鉛を用いるヒドロキシ化が工業的に実用性に乏し
い点に着目し、従来技術の二工程に対して一工程
で容易に5−ヒドロキシ誘導体を得る方法を見出
し、特願昭58−48769号として提案した。 In the above β-lactam production process, the present inventors have specifically identified (E) from the above compound (C) via (D).
We investigated the process leading to the 2,2-dimethyl-5-hydroxythiazolidine compound and found that the essential requirements, hydrazodiesterification using dimethylazodicarboxylate and hydroxylation using highly toxic lead tetraacetate, are industrially viable. Focusing on this lack of practicality, we discovered a method for easily obtaining 5-hydroxy derivatives in one step, as opposed to the two steps of the prior art, and proposed it as Japanese Patent Application No. 1987-48769.
上記先願発明によれば、前記化合物(C)を光増感
剤の存在で酸素酸化することによつて、一工程で
化合物(E)の5−ヒドロキシチアゾリジン誘導体を
製造することができる。この発明は化合物(C)の
2・2−ジメチルチアゾリジン誘導体をメタノー
ル、エタノール、アセトニトリルのような極性溶
媒に溶解し、更に原料化合物に対し10倍モル程度
のジメチルスルホアミド(DMSO)を添加すると
光増感酸素酸化が円滑に進行し、5−ヒドロキシ
チアゾリジン誘導体を60〜70%の収率で得ること
ができる。 According to the prior invention, the 5-hydroxythiazolidine derivative of compound (E) can be produced in one step by oxygen-oxidizing the compound (C) in the presence of a photosensitizer. In this invention, the 2,2-dimethylthiazolidine derivative of compound (C) is dissolved in a polar solvent such as methanol, ethanol, or acetonitrile, and dimethylsulfamide (DMSO) is added in an amount approximately 10 times the molar amount of the starting compound. Sensitized oxygen oxidation proceeds smoothly, and 5-hydroxythiazolidine derivatives can be obtained in a yield of 60 to 70%.
本発明者等は更に、この光増感酸素酸化方法を
発展させるべく種々検討の結果、上記の反応を非
プロトン性溶媒中で低温で反応を行なうことによ
つて、中間体として、
一般式
(式中のR1は低級アルキル基であり、R2はアミノ
保護基である)で表わされる2・2−ジメチル−
5−ヒドロペルオキシチアゾリジン誘導体がほぼ
定量的に生成することを見出した。 As a result of various studies to develop this photosensitized oxygen oxidation method, the inventors of the present invention further conducted the above reaction in an aprotic solvent at a low temperature to produce an intermediate with the general formula 2,2-dimethyl- (in the formula, R 1 is a lower alkyl group and R 2 is an amino protecting group)
It has been found that 5-hydroperoxythiazolidine derivatives are produced almost quantitatively.
この5−ヒドロペルオキシド体()は、ジメ
チルスルフイド、トリフエニルホスフイン等の適
当な還元剤の作用で下記式に従つて定量的に5−
ヒドロキシ体()に誘導することができる。 This 5-hydroperoxide () is quantitatively converted into 5-hydroperoxide by the action of an appropriate reducing agent such as dimethyl sulfide or triphenylphosphine according to the following formula.
It can be induced into the hydroxy form ().
したがつて、本発明は、()式で表わされる
2・2−ジメチルチアゾリジン誘導体を非プロト
ン性溶媒に溶解し、低温で光増感酸素酸化反応を
行ない、次いで生成する()式化合物を還元す
ることを特徴とする。上記反応式に基づく前段お
よび後段の転化率は何れもほぼ定量的であるの
で、結局、5−ヒドロキシ化反応収率は90〜95%
あるいはそれ以上の好成績で達成される。これは
先願発明における60〜70%収率に対して極めて改
善された方法であるといえる。 Therefore, the present invention involves dissolving a 2,2-dimethylthiazolidine derivative represented by the formula () in an aprotic solvent, performing a photosensitized oxygen oxidation reaction at a low temperature, and then reducing the resulting compound of the formula (). It is characterized by Since the conversion rates in the first and second stages based on the above reaction formula are almost quantitative, the 5-hydroxylation reaction yield is 90 to 95%.
Or even better. This method can be said to be a much improved method compared to the 60-70% yield in the prior invention.
光増感剤は従来公知のものが使用され、通常、
メチレンブルー、チオニン、クロロフイル、テト
ラフエニルポルフイン、場合により高分子に保持
されたローズベンガル等が使用できる。 Conventionally known photosensitizers are used, and usually,
Methylene blue, thionine, chlorophyll, tetraphenylporphine, rose bengal supported in a polymer, etc. can be used.
反応媒体としては必ず非プロトン性有機溶媒が
使用されなければならない。一般に、ベンゼン、
トルエン等の芳香族炭化水素、アセトン、メチル
エチルケトン等のケトン類、酢酸エチル等のエス
テル類、テトラヒドロフラン、ジオキサン等のエ
ーテル類などの非プロトン性有機溶媒が使用され
る。本発明の方法において、メタノール、エタノ
ールの如きプロトン性溶媒を使用するときは
()式の5−ヒドロキシペルオキシド体は数%
しか生成されない。 An aprotic organic solvent must always be used as the reaction medium. Generally, benzene,
Aprotic organic solvents such as aromatic hydrocarbons such as toluene, ketones such as acetone and methyl ethyl ketone, esters such as ethyl acetate, and ethers such as tetrahydrofuran and dioxane are used. In the method of the present invention, when a protic solvent such as methanol or ethanol is used, the 5-hydroxyperoxide of formula () is present in a few percent.
only generated.
本発明の前段の反応で生成される()式の5
−ヒドロペルオキシド体はそれ自体文献未載の新
規化合物である。この化合物は単離することもで
きるが、分解を防ぐために反応は低温で行なう必
要がある。一般に−20℃〜0℃の温度で行なうの
が好ましい。後段で行なわれる還元反応にも前段
の反応と同じ溶媒を使用できるので、中間体の単
離を行なわずにそのまま還元処理を行なうことが
でき、それによつて全体の収率の向上を図ること
が便利である。 5 of formula () produced in the first stage reaction of the present invention
-Hydroperoxide itself is a new compound that has not been described in any literature. The compound can be isolated, but the reaction must be carried out at low temperatures to prevent decomposition. It is generally preferred to carry out the reaction at a temperature of -20°C to 0°C. Since the same solvent can be used for the subsequent reduction reaction as in the previous reaction, the reduction process can be carried out without isolating the intermediate, thereby improving the overall yield. It's convenient.
本発明は一般に次の要領で実施することができ
る。先ず、2・2−ジメチルチアゾリジン誘導体
を20〜30倍容量の上記した非プロトン性有機溶媒
に溶解させ、溶液中の2・2−ジメチルチアゾリ
ジン誘導体の重量基準で0.5〜5重量%の光増感
剤を添加した後、細管より酸素を吹き込みなが
ら、成る可く低温で、好ましくは−20゜〜0℃で
光照射を行なう。反応は上記した一般用光照射ラ
ンプを用いて、1.5〜3時間で終了する。反応の
終了は採取した試料の薄層クロマトグラフイ分析
による原料化合物の消失によつて確認できる。生
成する5−ヒドロペルオキシ−2・2−ジメチル
チアゾリジン誘導体は不安定であり、室温で徐々
に分解するので、本発明の目的を達成するには前
記反応混合物中にほぼ当量の還元剤を加えて直接
還元処理を行なうのがよい。この還元反応は室温
で容易に進行し、通常1時間程度の撹拌で終了す
る。精製をカラムクロマトグラフイで行なうと、
高純度の5−ヒドロキシ体が得られる。 The invention can generally be practiced as follows. First, the 2,2-dimethylthiazolidine derivative is dissolved in 20 to 30 times the volume of the above-mentioned aprotic organic solvent, and 0.5 to 5% by weight of the 2,2-dimethylthiazolidine derivative is photosensitized based on the weight of the 2,2-dimethylthiazolidine derivative in the solution. After adding the agent, light irradiation is carried out at as low a temperature as possible, preferably -20° to 0°C, while blowing oxygen through a thin tube. The reaction is completed in 1.5 to 3 hours using the general-purpose light irradiation lamp described above. Completion of the reaction can be confirmed by the disappearance of the raw material compound by thin layer chromatography analysis of the collected sample. Since the resulting 5-hydroperoxy-2,2-dimethylthiazolidine derivative is unstable and gradually decomposes at room temperature, approximately an equivalent amount of reducing agent is added to the reaction mixture to achieve the object of the present invention. It is better to perform direct reduction treatment. This reduction reaction proceeds easily at room temperature and is usually completed after stirring for about 1 hour. When purification is performed by column chromatography,
A highly purified 5-hydroxy compound is obtained.
光照射ランプは高圧水銀ランプ、ハロゲンラン
プ、タングステンランプ、ナトリウムランプなど
一般用のランプが使用される。 As the light irradiation lamp, general lamps such as high-pressure mercury lamps, halogen lamps, tungsten lamps, and sodium lamps are used.
以下に実施例で本発明を説明する。 The present invention will be explained below with reference to Examples.
実施例 1
5−ヒドロペルオキシ−5−メトキシカルボニ
ル−2・2−ジメチルチアゾリジンの製造
3−ベンゾイル−4−メトキシカルボニル−
2・2−ジメチルチアゾリジン0.279gをテトラ
ヒドロフラン5mlに溶解し、これに光増感剤とし
てテトラフエニルポルフイリン15mlを加えた。反
応液を0℃に保ちながら細管から反応液中に酸素
を吹き込みつつ、500Wハロゲンランプを用いて
3時間光照射を行なつた。採取試料の薄層クロマ
トグラフイ(シリカゲル、ベンゼン:酢酸エチ
ル:メタノール=10:4:1)分析によつてRf
=0.68の原料化合物が消失し、Rf=0.58の生成物
の存在を確認した。溶媒のテトラヒドロフランを
減圧下に低温で留去し、低温カラムクロマトグラ
フイ(0℃シリカゲル、ベンゼン:酢酸エチル=
3:2)によりRf=0.58生成物を分離すると、無
色油状の3−ベンゾイル−5−ヒドロペルオキシ
−4−メトキシカルボニル−2・2−ジメチルチ
アゾリジン0.296gが得られた。収率95%(室温
で徐々に分解)。Example 1 Production of 5-hydroperoxy-5-methoxycarbonyl-2,2-dimethylthiazolidine 3-benzoyl-4-methoxycarbonyl-
0.279 g of 2,2-dimethylthiazolidine was dissolved in 5 ml of tetrahydrofuran, and 15 ml of tetraphenylporphyrin was added as a photosensitizer. Light irradiation was performed for 3 hours using a 500W halogen lamp while blowing oxygen into the reaction solution from a thin tube while keeping the reaction solution at 0°C. Rf was determined by thin layer chromatography (silica gel, benzene: ethyl acetate: methanol = 10:4:1) analysis of the collected sample.
The raw material compound with Rf = 0.68 disappeared and the presence of a product with Rf = 0.58 was confirmed. The solvent tetrahydrofuran was distilled off at a low temperature under reduced pressure, and low-temperature column chromatography (0°C silica gel, benzene:ethyl acetate =
Separation of the Rf=0.58 product by 3:2) gave 0.296 g of 3-benzoyl-5-hydroperoxy-4-methoxycarbonyl-2,2-dimethylthiazolidine as a colorless oil. Yield 95% (gradual decomposition at room temperature).
NMR(ベンゼン−d6):δ2.10(S、3H)
2.20(S、3H)
3.15(S、3H)
5.60(S、1H)
5.75(S、1H)
7.20〜7.80(m、5H)
IR:3230、1740、1620cm-1
実施例 2
5−ヒドロペルオキシド体(C)から5−ヒドロキ
シ体(E)の製造
実施例1で得られた3−ベンゾイル−5−ヒド
ロペルオキシ−4−メトキシカルボニル−2・2
−ジメチルチアゾリジン0.296gをテトラヒドロ
フランに溶解し、還元剤としてトリフエニルホス
フイン0.262gを加え、室温で1時間撹拌後カラ
ムクロマトグラフイ(シリカゲル、ベンゼン:酢
酸エチル=3:2)により、3−ベンゾイル−5
−ヒドロキシ−4−メトキシカルボニル−2・2
−ジメチルチアゾリジン0.253gを得た。収率90
%。NMR (benzene- d6 ): δ2.10 (S, 3H) 2.20 (S, 3H) 3.15 (S, 3H) 5.60 (S, 1H) 5.75 (S, 1H) 7.20-7.80 (m, 5H) IR: 3230, 1740, 1620 cm -1 Example 2 Production of 5-hydroxy compound (E) from 5-hydroperoxide compound (C) 3-benzoyl-5-hydroperoxy-4-methoxycarbonyl-2 obtained in Example 1・2
-Dissolve 0.296 g of dimethylthiazolidine in tetrahydrofuran, add 0.262 g of triphenylphosphine as a reducing agent, and stir for 1 hour at room temperature. -5
-Hydroxy-4-methoxycarbonyl-2.2
-0.253 g of dimethylthiazolidine was obtained. Yield 90
%.
融点:170〜171℃(分解)
NMR(CDCl3):δ2.00(S、3H)2.15(S、
3H)
3.20(d、1H)3.70(S、3H)
5.00(S、1H)5.60(d、1H)
7.50(S、5H)
IR:3230、1740、1620cm-1
実施例 3
3−アセチル−4−メトキシカルボニル−2・
2−ジメチルチアゾリジン0.217gをトルエン5
mlに溶解し、光増感剤としてメチレンブルー10mg
を加え、反応液を0℃に保ちながら細管より酸素
を吹き込みつつ高圧水銀ランプで90分間照射し
た。薄層クロマトグラフイ(シリカゲル、ベンゼ
ン:酢酸エチル:メタノール=10:4:1)で原
料化合物が消失し、5−ヒドロペルオキシ体が確
認された。次いで反応混合物中にトリフエニルホ
スフイン0.262gを加え、室温で1時間撹拌した
後、カラムクロマトグラフイ(シリカゲル、ベン
ゼン:酢酸エチル=3:2)により3−アセチル
−5−ヒドロキシ−4−メトキシカルボニル−
2・2−ジメチルチアゾリジン0.222gを得た。
収率95%。Melting point: 170-171℃ (decomposition) NMR (CDCl 3 ): δ2.00 (S, 3H) 2.15 (S,
3H) 3.20 (d, 1H) 3.70 (S, 3H) 5.00 (S, 1H) 5.60 (d, 1H) 7.50 (S, 5H) IR: 3230, 1740, 1620 cm -1 Example 3 3-acetyl-4- Methoxycarbonyl-2.
2-dimethylthiazolidine 0.217g to toluene 5
10mg of methylene blue as photosensitizer dissolved in ml
was added, and the reaction solution was irradiated for 90 minutes with a high-pressure mercury lamp while blowing oxygen through a capillary while keeping the reaction solution at 0°C. The raw material compound disappeared by thin layer chromatography (silica gel, benzene: ethyl acetate: methanol = 10:4:1), and a 5-hydroperoxy compound was confirmed. Next, 0.262 g of triphenylphosphine was added to the reaction mixture, and after stirring at room temperature for 1 hour, 3-acetyl-5-hydroxy-4-methoxy was purified by column chromatography (silica gel, benzene: ethyl acetate = 3:2). Carbonyl-
0.222 g of 2,2-dimethylthiazolidine was obtained.
Yield 95%.
NMR(CDCl3):δ1.90(S、3H)2.06(S、
3H)
2.10(S、3H)3.20(broad 1H)
3.85(S、3H)4.99(S、1H)
5.76(S、1H)
IR:3200、1740、1615cm-1
比較例
この比較例はプロトン溶媒として極性溶媒であ
るメタノールを用いた場合を説明する。3−ベン
ゾイル−4−メトキシカルボニル−2・2−ジメ
チルチアゾリジン0.279gをメタノール5mlに溶
解したほか、実施例1に記載の方法と全く同じ条
件下に10時間光照射を行なつた。しかし、カラム
クロマトグラフイによる3−ベンゾイル−5−ヒ
ドロペルオキシ−4−メトキシカルボニル−2・
2−ジメチルチアゾリジンの収量は僅か0.022
g、収率7%にすぎなかつた。NMR (CDCl 3 ): δ1.90 (S, 3H) 2.06 (S,
3H) 2.10 (S, 3H) 3.20 (broad 1H) 3.85 (S, 3H) 4.99 (S, 1H) 5.76 (S, 1H) IR: 3200, 1740, 1615 cm -1 Comparative example This comparative example is polar as a proton solvent. A case using methanol as a solvent will be explained. In addition to dissolving 0.279 g of 3-benzoyl-4-methoxycarbonyl-2,2-dimethylthiazolidine in 5 ml of methanol, light irradiation was carried out for 10 hours under exactly the same conditions as described in Example 1. However, by column chromatography, 3-benzoyl-5-hydroperoxy-4-methoxycarbonyl-2.
The yield of 2-dimethylthiazolidine is only 0.022
g, yield was only 7%.
Claims (1)
あり、R2はアミノ保護基である)で表わされる
2・2−ジメチルチアゾリジン誘導体を非プロト
ン性溶媒に溶解し、低温で光増感反応を行ない、
次いで生成する 一般式 (但し、式中のR1およびR2は前記の意味を有す
る)で表わされる2・2−ジメチル−5−ヒドロ
ペルオキシチアゾリジン誘導体の5−ヒドロペル
オキシ基を還元することを特徴とする2・2−ジ
メチル−5−ヒドロキシチアゾリジン誘導体の製
造方法。[Claims] 1. General formula (However, R 1 in the formula is hydrogen or a lower alkyl group, and R 2 is an amino protecting group) is dissolved in an aprotic solvent and photosensitized at low temperature. carry out the reaction,
Then generate the general formula (However, R 1 and R 2 in the formula have the above-mentioned meanings.) - A method for producing a dimethyl-5-hydroxythiazolidine derivative.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59115421A JPS60260567A (en) | 1984-06-07 | 1984-06-07 | Production of 2,2-dimethyl-5-hydroxythiazolidine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59115421A JPS60260567A (en) | 1984-06-07 | 1984-06-07 | Production of 2,2-dimethyl-5-hydroxythiazolidine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60260567A JPS60260567A (en) | 1985-12-23 |
JPS6245231B2 true JPS6245231B2 (en) | 1987-09-25 |
Family
ID=14662152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59115421A Granted JPS60260567A (en) | 1984-06-07 | 1984-06-07 | Production of 2,2-dimethyl-5-hydroxythiazolidine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60260567A (en) |
-
1984
- 1984-06-07 JP JP59115421A patent/JPS60260567A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60260567A (en) | 1985-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS633854B2 (en) | ||
JPH01104095A (en) | Manufacture of methylene derivative of androsta-1,4-diene-3,17-dione | |
JPH054981A (en) | Hydroquinone derivative | |
RU2448957C2 (en) | Fluorinated catharantine derivatives, their obtaining and application as precursors of dimeric vinca alkaloids | |
JPS6245231B2 (en) | ||
JPS5832884A (en) | Production of 3-exomethylenecepham derivative | |
JPH0129792B2 (en) | ||
KR950008970B1 (en) | Process for preparing t'butyl ergoline derivatives | |
JP3171400B2 (en) | Hydroxycarbonyl derivative and method for producing the same | |
JPH05286894A (en) | New production of carboxylic acid ester or carboxylic acid thioster | |
SU712024A3 (en) | Method of preparing 4-thioxy-2-azetidinones | |
JP2557429B2 (en) | Cycloartenol-7-one derivative | |
JPS6245230B2 (en) | ||
FR3055627A1 (en) | METHOD OF PREPARING CDB-3877 COMPOUND | |
CN113045568A (en) | Method for preparing gamma-eudiosmin U | |
JPH0254829B2 (en) | ||
JPH0564632B2 (en) | ||
JPS5810390B2 (en) | Rifamycins and their manufacturing method | |
JPH05306256A (en) | 2-hydroxy-3-butenoic acid and its production | |
JPS638944B2 (en) | ||
JPS5845415B2 (en) | Trimethylcyclohexene derivative | |
JPS6036416B2 (en) | Method for producing 2-(cis-2-pentenyl)cyclopentanone derivative | |
JPS5814431B2 (en) | Method for producing cyclopentanone carboxylic acid ester derivatives | |
JPS6056689B2 (en) | Production method of cis-2-cycloalkene-1,4-diol | |
FR2737208A1 (en) | Fluorinated vindoline derivs - and their reaction products with catharanthine having anti-cancer properties |